Chronic Lymphocytic Leukemia and Follicular Lymphoma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma - a podcast by Dr Neil Love

from 2021-08-02T12:00

:: ::

Featuring perspectives from Dr Nathan H Fowler, Prof John G Gribben and Dr Brad S Kahl, including the following topics:

  • Introduction (0:00)
  • Choice of Front-Line Therapy for Chronic Lymphocytic Leukemia (CLL) (6:04)
  • Selection of a BTK Inhibitor for the Treatment of CLL (20:11)
  • Second-Line Therapy for CLL (27:50)
  • Third-Line Therapy for CLL; Ongoing Research: Combination Strategies, Noncovalent BTK Inhibitors, CAR T-Cell Therapy (35:46)
  • Selection of First- and Second-Line Treatment for Follicular Lymphoma (43:13)
  • Third-Line Therapy for Follicular Lymphoma: Tazemetostat, PI3K Inhibitors, CAR T-Cell Therapy  (49:33)

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love